Purdue Pharma and Sackler Family Reach $7.4 Billion Settlement Over Opioid Crisis
Purdue Pharma and Sackler family agree to a $7.4 billion settlement to address opioid crisis lawsuits, subject to court approval.
Subscribe to unlock this story
We really don't like cutting you off, but you've reached your monthly limit. At just $5/month, subscriptions are how we keep this project going. Start your free 7-day trial today!
Get StartedHave an account? Sign in
Overview
Purdue Pharma and the Sackler family have agreed to pay up to $7.4 billion to settle lawsuits related to the opioid crisis, significantly increasing their previous settlement by over $1 billion. The Sacklers will contribute $6.5 billion and Purdue $900 million. This deal aims to compensate victims and fund opioid addiction treatment, but requires court approval. The arrangement ends Sackler control over Purdue and restricts them from selling opioids in the U.S. Several state attorney generals participated in this negotiation, seeing it as a means to provide some closure to opioid crisis victims.
Report issue
Read both sides in 5 minutes each day
Analysis
Analysis unavailable for this viewpoint.
Articles (10)
Center (8)
History
- 8M
5 articles